Regen Biopharma, Inc. is a biotechnology company, which engages in the business of developing regenerative medical applications and advancing novel technologies through pre-clinical and Phase I and II clinical trials. It also focuses on mRNA and small molecule therapies for treating cancer and autoimmune disorders. The company was founded on April 24, 2012 and is headquartered in La Mesa, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Regen Biopharma Inc market cap is $202,923.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Regen Biopharma Inc 52 week high is $0.014 as of November 18, 2026.
Regen Biopharma Inc stock price today is $0.0001.
Regen Biopharma Inc stock price yesterday was $0.0001.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Regen Biopharma Inc's P/E ratio is -0.01.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Regen Biopharma Inc P/B ratio is -0.0192.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Regen Biopharma Inc 50-day moving average is $0.0001.